Churchill Capital Corp Shares Halted, News Pending
Save time and jump to the most important pieces.
Churchill Announces Redemption of Public Shares NEW YORK and ALTRINCHAM, England, Aug. 18, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill") (NASDAQ:CVII), a publicly-traded special purpose acquisition company, and CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, today announced that they have mutually agreed to terminate their previously announced merger agreement (the "Merger Agreement") due to IPO market conditions, effective today. "While market conditions are not favorab
Stockholders may elect to redeem shares of Class A Common Stock until 5:00 pm Eastern Time, August 9, 2024 NEW YORK, Aug. 5, 2024 /PRNewswire/ -- Churchill Capital Corp VII ("Churchill VII") (NASDAQ:CVII), a special purpose acquisition company, announced today that the deadline for Churchill VII stockholders to elect redemption of their shares of class A common stock of Churchill VII ("Class A Common Stock") in connection with the proposed business combination between CorpAcq Holdings Limited ("CorpAcq"), and Churchill VII (the "Business Combination") is extended until 5:00 P.M., Eastern Time on August 9, 2024. The redemption deadline is being extended so that stockholders will have sufficie
Expected Financing Would De-Risk Closing of Business Combination and is Anticipated to Support CorpAcq's Future Growth NEW YORK and ALTRINCHAM, England, Aug. 2, 2024 /PRNewswire/ -- CorpAcq Holdings Limited ("CorpAcq"), a corporate compounder with a proven track record of acquiring and supporting founder-led businesses, and Churchill Capital Corp VII ("Churchill VII") (NASDAQ:CVII), a special purpose acquisition company, today provided an update on planned equity or equity-linked financing in support of the previously announced business combination (the "Business Combination") between CorpAcq, CorpAcq Group Plc, a public limited company incorporated under the laws of England and Wales and an
In Excess of $605 Million Remains in Churchill VII's Trust Account after Stockholder Redemptions relating to the Extension
CorpAcq is a corporate compounder and preferred acquirer of founder-led small and medium-sized enterprises in the UK anchored by a diversified portfolio of 41 stable and profitable businesses Transaction is expected to provide CorpAcq with capital to optimize its balance sheet and the opportunity to fund accelerated growth and scale with a broader acquisition pipeline CorpAcq has grown revenue at an annual rate of 16% and adjusted EBITDA1 of 17% over the last 4 years including average organic revenue growth of 4% and subsidiary-level profit growth of 7%, respectively Transaction implies an initial enterprise value of approximately $1.58 billion, providing an attractive entry point for Chu
4 - Churchill Capital Corp VII (0001828248) (Issuer)
4 - Churchill Capital Corp VII (0001828248) (Issuer)
3 - Churchill Capital Corp VII (0001828248) (Issuer)
SC 13G/A - Churchill Capital Corp VII (0001828248) (Subject)
SC 13G - Churchill Capital Corp VII (0001828248) (Subject)
SC 13G - Churchill Capital Corp VII (0001828248) (Subject)
15-12G - Churchill Capital Corp VII (0001828248) (Filer)
8-K - Churchill Capital Corp VII (0001828248) (Filer)
25-NSE - Churchill Capital Corp VII (0001828248) (Subject)